Concepedia

Stephanie de Bono

SD

Statistics

Publications

34

Citations

6.4K

H-Index

23

Active since

2001

Affiliations

Eli Lilly (United States)(Current)

University of Oxford

Université Paris Cité

University of Occupational and Environmental Health Japan

NIHR Leeds Musculoskeletal Biomedical Research Unit

Stephanie de Bono is an author at Eli Lilly (United States) specializing in medicine, pharmacotherapy, and rheumatology.

ORCID

Publications per year

2001–2023

34

Publications

34

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

André C. Kalil, Thomas F. Patterson, Aneesh K. Mehta et al. · New England Journal of Medicine · 2020 · 1.9K citations · Full text

, , +14

Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis

Peter C. Taylor, Edward Keystone, Désirée van der Heijde et al. · New England Journal of Medicine · 2017 · 951 citations · Full text

, , +17

Baricitinib in Patients with Refractory Rheumatoid Arthritis

Mark C. Genovese, Joel Kremer, Omid Zamani et al. · New England Journal of Medicine · 2016 · 621 citations · Full text

, , +16

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial

Daniel J. Wallace, Richard Furie, Yoshiya Tanaka et al. · The Lancet · 2018 · 513 citations · Full text

, , +5

Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease‐Modifying Antirheumatic Drug Treatment

Roy Fleischmann, Michael Schiff, Désirée van der Heijde et al. · Arthritis & Rheumatology · 2016 · 423 citations · Full text

, , +15

1–5 of 34